↓ Skip to main content

The Development of AXL Inhibitors in Lung Cancer: Recent Progress and Challenges

Overview of attention for article published in Frontiers in oncology, March 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (64th percentile)
  • High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

twitter
1 X user
patent
1 patent

Citations

dimensions_citation
19 Dimensions

Readers on

mendeley
35 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The Development of AXL Inhibitors in Lung Cancer: Recent Progress and Challenges
Published in
Frontiers in oncology, March 2022
DOI 10.3389/fonc.2022.811247
Pubmed ID
Authors

Yun Beom Sang, Joo-Hang Kim, Chang-Gon Kim, Min Hee Hong, Hye Ryun Kim, Byoung Chul Cho, Sun Min Lim

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 35 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 35 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 6 17%
Student > Postgraduate 4 11%
Researcher 4 11%
Student > Bachelor 3 9%
Other 3 9%
Other 4 11%
Unknown 11 31%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 8 23%
Pharmacology, Toxicology and Pharmaceutical Science 4 11%
Medicine and Dentistry 4 11%
Chemistry 3 9%
Agricultural and Biological Sciences 2 6%
Other 2 6%
Unknown 12 34%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 December 2023.
All research outputs
#7,968,340
of 25,392,582 outputs
Outputs from Frontiers in oncology
#2,906
of 22,436 outputs
Outputs of similar age
#158,651
of 448,997 outputs
Outputs of similar age from Frontiers in oncology
#195
of 1,543 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 22,436 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 448,997 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.
We're also able to compare this research output to 1,543 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.